Blood-based biomarkers in mild behavioral impairment: an updated overview

Identifying individuals at-risk for dementia is one of the critical objectives of current research efforts, highlighting the need for simple, cost-effective, and minimally invasive biomarkers. Mild behavioral impairment (MBI), characterized by the emergence of persistent neuropsychiatric manifestati...

Full description

Bibliographic Details
Published in:Frontiers in Neurology
Main Authors: Efthalia Angelopoulou, Xenia Androni, Chiara Villa, Alexandros Hatzimanolis, Nikolaos Scarmeas, Sokratis Papageorgiou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Subjects:
Mild behavioral impairment
biomarkers
Alzheimer’s disease
dementia
neuropsychiatric symptoms
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1534193/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1534193/full

Similar Items